We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

In Vitro Integrity: Maximizing the Value of Plate-Based Assay Data
In Vitro Integrity: Maximizing the Value of Plate-Based Assay Data
Blog

Genedata’s Screener software aims to streamline data workflows and make analysis easier. We caught up with Dr. Oliver Leven, Head of Genedata Screener Business Europe, to discuss how we researchers can make data more standardized, accessible and shareable whilst not compromising on security and integrity.

Read More

Monitoring Pulmonary Exacerbation in Cystic Fibrosis: The Hunt for Urine-based Biomarkers Begins
The Search Begins: Urinary Biomarkers that Indicate Pulmonary Exacerbation in Cystic Fibrosis
Blog

A clinical trial has been launched to identify urine-based biomarkers which indicate lung flare-ups in cystic fibrosis. Researchers believe point-of-care monitoring will help people get treatment faster, improve patient outcomes and reduce healthcare costs.

Read More

The Digital Solutions Offering Complete Control over Bioprocessing Workflows
The Digital Solutions Offering Complete Control over Bioprocessing Workflows
Blog

Robust data management is integral to both academic researchers and scientists in the pharmaceutical industry, especially for those working with bioprocessing workflows. In this blog, Thermo Fisher Scientific’s Karen Velardi explains how the introduction of digital science solutions to the modern lab is transforming bioprocessing workflows by providing scientists with full control over procedures, data integrity and compliance

Read More

Plasmid Platform Promises a Unique Data Sharing Solution
Plasmid Platform Promises a Unique Data Sharing Solution
Blog

No scientist is an island, and to maximize the power of data, researchers have to share their results with the wider community. Now, GenScript's launch of its MolecularCloud platform suggests sharing plasmid data may become easier than ever before.

Read More

Developing Neuroprotective Therapies: Defending the Nervous System from Damage
Developing Neuroprotective Therapies: Defending the Nervous System from Damage
Blog

The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners recently announced the launch of Magnolia Neurosciences Corporation – a biopharmaceutical company advancing a new class of neuroprotective medicines.

Read More

Single Cell Analysis with the BD AbSeq Assay
Single Cell Analysis with the BD AbSeq Assay
Blog

New tools are enabling researchers to explore individual cells with unprecedented clarity, allowing RNA and protein expression levels to be simultaneously analyzed. In this blog, Brian Lilhanand, Global Platform Leader, Single Cell Multiomics, at BD, discusses how BD’s new AbSeq Assay can provide this targeted profiling and benefit immunology researchers.





Read More

From Growing Cells to Growing a Business
From Growing Cells to Growing a Business
Blog

How do you start, grow and run a successful life science company? To find out we spoke to Dr Yichen Shi, CEO of Axol Bioscience.

Read More

Improving Preclinical Diabetes Research
Improving Preclinical Diabetes Research
Blog

Dr. Sven Schönecker from Multi Channel Systems discusses exciting technological developments in the preclinical drug development space for diabetes

Read More

Moving Past Paper: Realizing the Potential of ELNs
Moving Past Paper: Realizing the Potential of ELNs
Blog

Electronic Laboratory Notebooks are becoming more popular as labs embrace digitization. ELN provider Biodata’s flagship offering, Labguru, has over 30,000 users worldwide. We caught up with Steve Yemm, recently appointed CEO of BioData, to ask him about the advantages of ELNs and the challenges they face in a digital market.

Read More

Why is China Becoming a Microfluidics Manufacturing Superpower?
Why is China Becoming a Microfluidics Manufacturing Superpower?
Blog

Many Chinese microfluidics companies are emerging and expanding, and it could be game-changing for the industry. We spoke with Yole Développement analyst, Sébastien Clerc, to learn more.

Read More